Drug Information
Drug General Information | Top | |||
---|---|---|---|---|
Drug ID |
D0FL2K
|
|||
Drug Name |
Cantrixil
|
|||
Synonyms |
UNII-5DVS457HEG; 5DVS457HEG; SCHEMBL19410294; TRX-E-002-1; cis-4-(p-hydroxyphenyl)-7,4'-dihydroxy-3',5'-dimethoxy-8-methylisoflavan; (+)-cis-4-(Para-hydroxyphenyl)-7,4-dihydroxy-3,5-dimethoxy-8-methylisoflavan; 1803036-93-2
Click to Show/Hide
|
|||
Indication | Ovarian cancer [ICD-11: 2C73; ICD-10: C56; ICD-9: 183] | Phase 1 | [1] | |
Company |
Kazia Therapeutics Sydney, Australia
|
|||
Structure |
Download2D MOL |
|||
Formula |
C24H24O6
|
|||
Canonical SMILES |
CC1=C(C=CC2=C1OCC(C2C3=CC=C(C=C3)O)C4=CC(=C(C(=C4)OC)O)OC)O
|
|||
InChI |
1S/C24H24O6/c1-13-19(26)9-8-17-22(14-4-6-16(25)7-5-14)18(12-30-24(13)17)15-10-20(28-2)23(27)21(11-15)29-3/h4-11,18,22,25-27H,12H2,1-3H3/t18-,22-/m0/s1
|
|||
InChIKey |
JFVVPUGGRUGRBJ-AVRDEDQJSA-N
|
|||
CAS Number |
CAS 1803036-93-2
|
|||
PubChem Compound ID |
References | Top | |||
---|---|---|---|---|
REF 1 | Clinical pipeline report, company report or official report of the Pharmaceutical Research and Manufacturers of America (PhRMA) |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.